Organon (OGN) Insider Deborah Leone Buys $240K of Stock
Deborah Leone added to her portfolio by purchasing 17,857 shares of Organon & Co. on June 12, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Deborah Leone bought 17,857 shares of Organon & Co. ($OGN) at an average price of $13.44, worth about $239,998.08, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $OGN is down 0.3% after 1 week, up 0.5% after 1 month and up 2.5% to date (from the $13.42 close on Jun 12, 2026).
OGN
Organon & Co.
Key Points
- Deborah Leone acquired 17,857 shares of Organon & Co. (NYSE:OGN) on June 12, 2026, at a price of $13.44 per share.
- The total value of the transaction reached approximately $239,998.08, adding to her recent activity in other equities.
- Several other insiders, including Robert Essner and Alan Ezekowitz, completed identical purchases on the same date.
Get $OGN trade alerts by text
We text you when insiders, Congress or big funds trade $OGN. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Organon & Co. alert may contain errors. Disclosures
Deborah Leone Buys Shares of Organon & Co.
Deborah Leone picked up 17,857 shares of Organon & Co. (NYSE:OGN) on June 12, 2026. The shares were acquired at a price of $13.44 each, bringing the total value of the transaction to $239,998.08. This trade follows her recent acquisition of Corebridge Financial shares earlier in the month.
Group Insider Buying at Organon & Co.
Leone wasn't the only person adding to a stake in the healthcare firm on June 12, 2026. Robert Essner also bought 17,857 shares at $13.44 each for a total of $239,998.08. Alan Ezekowitz acquired 17,857 shares at the exact same price and total value. Helene Gayle picked up 17,857 shares worth $239,998.08. Rochelle Lazarus added 17,857 shares for $239,998.08, and Cynthia Patton rounded out the group by purchasing 17,857 shares totaling $239,998.08. None of these transactions were carried out under pre-arranged Rule 10b5-1 trading plans.
Organon & Co. Stock Valuation and Price Context
The shares traded on the open market while sitting close to their peak levels for the year. The spot price on the day of the transaction was $13.44, while the 52-week high sits at $13.79 and the 52-week low rests at $5.69.
What Organon & Co. Does
Organon & Co. operates as a global healthcare company focusing on women's health solutions, biosimilars, and established pharmaceutical products. Headquartered in Jersey City, New Jersey, the firm develops and delivers contraception, fertility brands, and therapies for various medical conditions to international markets.
Looking Ahead at Upcoming Disclosures
Market participants will continue tracking insider transactions and upcoming financial reports for further direction on the healthcare provider's trajectory. The company's next earnings release is scheduled for November 9, 2026.
Related Filing Alerts
Source: Deborah Leone's Form 4 filing on $OGN (Jun 12, 2026). Find the original filing: OGN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts